Patients and baseline demographic characteristics
Nineteen patients were enrolled in the study and all of them received study treatment. The study was terminated early due to the changing landscape of therapies and the lack of a clear signal of benefit in the first 13 patients evaluable for PFS. Seventeen patients received at least one full cycle of study treatment. The patients on this trial had similar characteristics to the national averages in the United States.Detailed demographics for the enrolled patient population (Metastatic sites of the enrolled patient population (